Evercore ISI Group initiated coverage on Entrada Therapeutics
$TRDA
Biotechnology: Pharmaceutical Preparations
Health Care
Evercore ISI Group initiated coverage of Entrada Therapeutics with a rating of Outperform
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 12/6/2024 | $29.00 | Buy | ROTH MKM |
| 1/5/2024 | $22.00 | Outperform | Oppenheimer |
| 4/3/2023 | $25.00 | Buy | H.C. Wainwright |
| 11/24/2021 | Outperform | Evercore ISI Group | |
| 11/23/2021 | Outperform | Cowen & Co. | |
| 11/23/2021 | $29.00 | Neutral | Goldman Sachs |
8-K - Entrada Therapeutics, Inc. (0001689375) (Filer)
DEFA14A - Entrada Therapeutics, Inc. (0001689375) (Filer)
8-K - Entrada Therapeutics, Inc. (0001689375) (Filer)